Thermo Fisher Scientific Inc.
Dion J Weisler (Director) reports TMO insider transactions
About this filing
Thermo Fisher Scientific Inc. (TMO) filed Form 4 (insider transaction) with the SEC on Sep 29, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Dion J Weisler · Director
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Sep 26, 2026 | A · grantPhantom Stock UnitsFootnotes F1, F2 | +55.56 | — | — | 2,846.55 | Direct |
Footnotes
- F1 Convertible into Common Stock on a 1-for-1 basis.
- F2 Represents stock units credited to the Reporting Person's account as of September 26, 2026, at a price of $675.00 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control.
More TMO filings
- 4
Filed Oct 30, 2026
- 4
Filed Oct 30, 2026
- 8-K
Filed Oct 30, 2026
- 10-Q
Filed Oct 30, 2026
- 144
Filed Oct 28, 2026
- 8-K
Filed Oct 21, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.